Cargando…
Ameliorative Effects of Lactobacillus plantarum HAC01 Lysate on 3T3-L1 Adipocyte Differentiation via AMPK Activation and MAPK Inhibition
Lactobacillus plantarum HAC01 has been shown to effectively treat metabolic diseases. However, the precise pharmacological effects and molecular mechanisms of L. plantarum HAC01 remain unclear. In this study, we investigate the anti-adipogenic effects of L. plantarum HAC01 lysate and its associated...
Autores principales: | Kim, Jong-Yeon, Park, Eun-Jung, Lee, Hae-Jeung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180524/ https://www.ncbi.nlm.nih.gov/pubmed/35682579 http://dx.doi.org/10.3390/ijms23115901 |
Ejemplares similares
-
Lactobacillus plantarum HAC01 Supplementation Improves Glycemic Control in Prediabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Mi-Ra, et al.
Publicado: (2021) -
Lactobacillus plantarum ATG-K2 and ATG-K6 Ameliorates High-Fat with High-Fructose Induced Intestinal Inflammation
por: Park, Miey, et al.
Publicado: (2021) -
Combination of Lactobacillus plantarum HAC03 and Garcinia cambogia Has a Significant Anti-Obesity Effect in Diet-Induced Obesity Mice
por: Kang, Youn-Goo, et al.
Publicado: (2023) -
Lactobacillus plantarum LG42 Isolated from Gajami Sik-Hae Inhibits Adipogenesis in 3T3-L1 Adipocyte
por: Park, Jeong-Eun, et al.
Publicado: (2013) -
Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01 in patients undergoing bowel preparation
por: Luigi, Bonavina, et al.
Publicado: (2019)